Vietnam Vaccine Market

Market Overview:

Vietnam vaccine market size reached USD 851 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,468 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The increasing awareness about the importance of immunization in preventive healthcare measures, rising prevalence of dengue and hand, foot, and mouth disease, and rapid advancements in vaccine delivery methods represent some of the key factors driving the market.

Vaccine helps the immune system of the body in recognizing and fight specific diseases by imitating the presence of the disease-causing germ without causing illness. It undergoes rigorous testing methods to ensure its safety and efficacy for use. It is stored and transported under controlled conditions to maintain its potency. It is available in various forms, which include live attenuated, inactivated, subunit, mRNA, and viral vector vaccines, each tailored to specific pathogens. It aids in preventing infectious diseases, reducing the risk of illness, complications, and transmission. It also helps in the eradication or near-elimination of several deadly diseases, including smallpox and polio. It is routinely administered to infants and children to protect them from diseases like measles, mumps, rubella, and pertussis. It is recommended for adults, including influenza, pneumococcal, and hepatitis vaccines. Besides this, as it is more cost-effective than treating diseases, the demand for vaccine is increasing across Vietnam.

Vietnam Vaccine Market Trends:

The growing emphasis on preventive healthcare, coupled with the increasing awareness about the importance of immunization, represents one of the primary factors catalyzing the demand for vaccines in Vietnam. Additionally, the increasing prevalence of dengue and hand, foot, and mouth disease is strengthening the growth of the market in the country. Along with this, there is a rise in expansion of vaccine coverage to include a broader range of diseases, including Hepatitis B, Japanese encephalitis, and human papillomavirus (HPV). Moreover, governing authorities and healthcare organizations in Vietnam are intensifying efforts to expand vaccination programs. Apart from this, the development of innovative technologies, such as mRNA vaccines, is offering a favorable market outlook. These advancements allow for quicker and more adaptable responses to emerging infectious diseases. Along with this, rapid advancements in vaccine delivery methods, including needle-free injections, nasal sprays, and microneedle patches, are making vaccines more convenient and less intimidating, potentially increasing vaccination rates. Furthermore, several biotechnology companies and pharmaceutical giants operating in the country are investing in research and development (R&D) of vaccines for various diseases, including cancer and HIV. Moreover, the growing adoption of digital health solutions is enhancing vaccine distribution and monitoring, contributing to the market growth. Besides this, increasing global travel, and a focus on disease prevention in aging populations are propelling the market growth. In addition, regulatory support and collaborations between public and private sectors are strengthening the growth of the market. The governing agencies are incentivizing vaccine development through funding, fast-track approvals, and initiatives like COVAX, while partnerships between pharmaceutical companies and research institutions foster innovation.

Vietnam Vaccine Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

The report has provided a detailed breakup and analysis of the market based on the product type. This includes multivalent vaccine and monovalent vaccine.

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

A detailed breakup and analysis of the market based on the treatment type have also been provided in the report. This includes preventive vaccine and therapeutic vaccine.

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others.

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes intramuscular and subcutaneous administration, oral administration, and others.

Patient Type Insights:

• Pediatric
• Adult

The report has provided a detailed breakup and analysis of the market based on patient type. This includes pediatric and adult.

Indication Insights:

• Bacterial Diseases
  • Meningococcal Disease
  • Pneumococcal Disease
  • Diphtheria/Tetanus/Pertussis (DPT)
  • Tuberculosis
  • Haemophilus Influenzae (Hib)
  • Typhoid
  • Others
• Viral Diseases
  • Hepatitis
  • Influenza
  • Human Papillomavirus (HPV)
  • Measles/Mumps/Rubella (MMR)
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Vietnamese Encephalitis
  • Rubella
  • Polio
  • Rabies
  • Dengue
  • Others

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes bacterial diseases (meningococcal disease, pneumococcal disease, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid, and others) and viral diseases (hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Vietnamese encephalitis, rubella, polio, rabies, dengue, and others).

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospital pharmacies, retail pharmacies, institutional sales, and others.

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, vaccination centers, academic and research institutes, and others.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Vaccine Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam vaccine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Vietnam vaccine market?
• What is the breakup of the Vietnam vaccine market on the basis of product type?
• What is the breakup of the Vietnam vaccine market on the basis of treatment type?
• What is the breakup of the Vietnam vaccine market on the basis of technology?
• What is the breakup of the Vietnam vaccine market on the basis of route of administration?
• What is the breakup of the Vietnam vaccine market on the basis of patient type?
• What is the breakup of the Vietnam vaccine market on the basis of indication?
• What is the breakup of the Vietnam vaccine market on the basis of distribution channel?
• What is the breakup of the Vietnam vaccine market on the basis of end user?
• What are the various stages in the value chain of the Vietnam vaccine market? 
• What are the key driving factors and challenges in the Vietnam vaccine?
• What is the structure of the Vietnam vaccine market and who are the key players?
• What is the degree of competition in the Vietnam vaccine market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam vaccine market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam vaccine market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam vaccine industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.